Skip to main content
Damodar Industries Limited logo

Damodar Industries Limited — Investor Relations & Filings

Ticker · DAMODARIND ISIN · INE497D01022 LEI · 335800NO1TDB7I9I7L24 BSE.NS Manufacturing
Filings indexed 972 across all filing types
Latest filing 2024-05-24 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS DAMODARIND

About Damodar Industries Limited

http://www.damodargroup.com

Damodar Industries Limited specializes in the manufacturing of synthetic and cotton yarns, with a primary focus on fancy yarns, melange yarns, and specialty blended yarns. The company operates advanced spinning facilities to produce a diverse range of products, including polyester, viscose, and cotton blends tailored for various textile applications. Its operations encompass the development of customized yarn solutions for garment manufacturers and exporters worldwide. By leveraging integrated production capabilities and technical expertise, the company provides high-performance materials for the global apparel and home furnishing markets. The product range is characterized by a commitment to quality and innovation in yarn textures and compositions.

Recent filings

Filing Released Lang Actions
Please find the attached
Interim / Quarterly Report Classification · 95% confidence The document contains an extract of audited financial results for the quarter and year ended March 31, 2024, with detailed financial figures such as total income, net profit, earnings per share, and notes referencing SEBI regulations. This indicates it is a financial report containing substantive financial data. The document length is 15,000 characters, which is substantial and not a mere announcement or notice. The presence of quarterly and annual audited financial results suggests it is an Interim / Quarterly Report (IR) rather than a full Annual Report (10-K) because it includes quarterly data and is labeled as an extract of quarterly/annual results. Other parts of the document include notices unrelated to financial reporting, which do not affect the classification of the main financial content. Therefore, the document is best classified as an Interim / Quarterly Report (IR). FY 2024
2024-05-24 English
Please find the attached herewith
Regulatory Filings Classification · 95% confidence The document text is extremely short (only 100 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. According to the MENU VS MEAL RULE, this is not a report but likely a regulatory or administrative filing. Given the lack of content, the best fit is Regulatory Filings (RNS) as a fallback category.
2024-05-24 English
Updates
Board/Management Information Classification · 95% confidence The document text is very short (1060 characters) and primarily announces the appointment of a Secretarial Auditor, including details about the auditing firm and their expertise. There is no financial data, no detailed report, or regulatory certification. The content focuses on management/board-related information, specifically about an auditor appointment, which is a change in company oversight personnel. This fits best under Board/Management Information (MANG).
2024-05-23 English
Please Find attachement herewith
Regulatory Filings Classification · 95% confidence The document is a formal letter from Damodar Industries Limited addressed to stock exchanges (NSE and BSE) informing about the appointment of an Internal Auditor and a Secretarial Auditor for the fiscal year 2024-25. It includes disclosures required under SEBI circular CIR/CFD/CMD/4/2015 dated 9th September 2015. The content is about board decisions regarding auditor appointments and related disclosures, not a financial report or audit report itself. The document is a regulatory announcement informing the exchanges and public about these appointments, consistent with compliance requirements. It does not contain financial statements, audit opinions, or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance announcement.
2024-05-23 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Damodar Industries Limited regarding the outcomes of a Board Meeting held on May 23, 2024. It includes approval of audited financial results for the quarter and year ended March 31, 2024, appointment of auditors, and scheduling of the 36th Annual General Meeting. The document contains substantive financial data (audited financial results and statement of assets and liabilities) and detailed disclosures about auditor appointments and internal audit. It is not merely an announcement of a report publication but includes actual financial results and related approvals. The content aligns with a comprehensive interim or annual financial report rather than a brief announcement or certification. Given the quarterly and annual financial results are included, this fits best as an Interim / Quarterly Report (IR).
2024-05-23 English
Please Find the attachment herewith Financial Result for the Quarter and Year Ended 31st March, 2024
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Damodar Industries Limited regarding the outcomes of a Board Meeting held on May 23, 2024. It includes approval of audited financial results for the quarter and year ended March 31, 2024, appointment of auditors (cost auditor, internal auditor, secretarial auditor), and approval of convening the 36th Annual General Meeting. The document references Regulation 30(2) of SEBI Listing Obligations and Disclosure Requirements, and includes disclosures required under SEBI circular CIR/CFD/CMD/4/2015. The content is a formal regulatory announcement of board decisions and financial results approval, not the full financial report itself. It also includes auditor appointment disclosures and meeting details. The document length is about 15,000 characters, but the content is primarily an announcement of board meeting outcomes and approvals, not the full audited financial statements or detailed financial analysis. Therefore, it fits best under Regulatory Filings (RNS) as a regulatory announcement of board meeting outcomes and financial results approval, rather than the Annual Report (10-K) or Audit Report (AR) themselves.
2024-05-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.